Urokinase‐type plasminogen activator and its inhibitor secreted by cultured human monocyte‐macrophages

Human blood monocytes in culture differentiate to macrophagelike cells within 1 week. Coinciding with this morphological transition the cells started releasing increasing amounts of the serine proteinase plasminogen activator (PA; Mr 56,000) of the urokinase (u‐PA) type and the proteinase inhibitor alpha‐2‐macroglobulin (α2M). Unlike the cell‐associated PA activity, which was also readily detected in fresh monocytes, the activity secreted into the serum‐free culture medium could be measured only after treatment of the samples with sodium dodecyl sulphate. Heat or acid treatment of the medium was not sufficient to reveal the PA activity, suggesting that, apart from α2M, another PA‐inhibiting substance was present in the culture medium. The inhibitor (Mr 65,000) was found to be synthesized by macrophages and specifically inhibited u‐PA activity but not tissue‐type PA (t‐PA) or plasmin activity. Dexamethasone decreased the secretion of PA by differentiated macrophages without affecting the production of α2M or the PA inhibitor. Dexamethasone also inhibited the morphological differentiation of the cells when added to the monocyte‐phase cells.

[1]  K. Kohn,et al.  Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage. , 1985, Biochemistry.

[2]  W. Schleuning,et al.  Complex-formation and inhibition of urokinase by blood plasma proteins. , 1983, The Biochemical journal.

[3]  R. W. Scott,et al.  Purification of human protease nexin. , 1983, The Journal of biological chemistry.

[4]  D. Lawrence,et al.  Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Birkedal‐Hansen,et al.  Production of three plasminogen activators and an inhibitor in keratinocyte cultures. , 1983, Biochimica et biophysica acta.

[6]  D. Collen,et al.  Complexes between tissue-type plasminogen activator and proteinase inhibitors in human plasma, identified with an immunoradiometric assay. , 1983, The Journal of laboratory and clinical medicine.

[7]  J. Zeuthen,et al.  Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. , 1982, Biochemistry.

[8]  C. Francis,et al.  Secretion of plasminogen activator by the human macrophage‐like cell line, GCT: separation from colony‐stimulating and erythropoiesis‐enhancing activities , 1982, British Journal of Haematology.

[9]  H. Chapman,et al.  Macrophage fibrinolytic activity: Identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor , 1982, Cell.

[10]  W. Arend,et al.  Characteristics of fibrinolytic enzyme release from human monocytes. , 1981, Clinical and experimental immunology.

[11]  D. Collen,et al.  Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. , 1981, The Journal of biological chemistry.

[12]  D. Crutchley,et al.  HUMAN FIBROBLASTS PRODUCE INHIBITOR DIRECTED AGAINST PLASMINOGEN ACTIVATOR WHEN TREATED WITH GLUCOCORTICOIDS * , 1981, Annals of the New York Academy of Sciences.

[13]  O. Saksela.  Radial caseinolysis in agarose: a simple method for detection of plasminogen activator in the presence of inhibitory substances and serum. , 1981, Analytical biochemistry.

[14]  L. Brown,et al.  The inhibition of high and low molecular weight urokinase in plasma. , 1980, Blood.

[15]  J. David,et al.  Plasminogen activator production by human monocytes. I. Enhancement by activated lymphocytes and lymphocyte products. , 1979, Journal of immunology.

[16]  M. Vuento,et al.  Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. , 1979, The Biochemical journal.

[17]  C. Sorg,et al.  The production of fibrinolysis inhibitors as a parameter of the activation state in murine macrophages , 1979, European journal of immunology.

[18]  W. Arend,et al.  Neutral protease secretion by human monocytes. Effect of surface-bound immune complexes , 1979, The Journal of experimental medicine.

[19]  Z. Werb.  Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions , 1978, The Journal of experimental medicine.

[20]  E. Vahtera,et al.  Interaction of urokinase with alpha2-macroglobulin investigated by isoelectric focusing. Evidence for non-specific dissociable binding. , 1978, The Biochemical journal.

[21]  R. Roblin,et al.  Concomitant secretion by transformed SVWI38-VA13-2RA cells of plasminogen activator(s) and substance (s) which prevent their detection. , 1978, Biochemical and biophysical research communications.

[22]  A. Allison,et al.  Identification of human mononuclear leucocyte populations by esterase staining. , 1977, Clinical and experimental immunology.

[23]  J. Vassalli,et al.  Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate , 1977, Cell.

[24]  A. Vaheri,et al.  Cultured human monocytes synthesize and secrete alpha2-macroglobulin , 1977, The Journal of experimental medicine.

[25]  L. Holmberg,et al.  Purification of urokinase by affinity chromatography. , 1976, Biochimica et biophysica acta.

[26]  K. Nilsson,et al.  Establishment and characterization of a human histiocytic lymphoma cell line (U‐937) , 1976, International journal of cancer.

[27]  Z. Cohn,et al.  INDUCTION OF MACROPHAGE PLASMINOGEN ACTIVATOR BY ENDOTOXIN STIMULATION AND PHAGOCYTOSIS , 1974, The Journal of experimental medicine.

[28]  J. Unkeless,et al.  SECRETION OF PLASMINOGEN ACTIVATOR BY STIMULATED MACROPHAGES , 1974, The Journal of experimental medicine.

[29]  A. Barrett,et al.  The interaction of α2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism , 1973 .

[30]  M. Welch,et al.  Studies of radioiodinated fibrinogen. I. Physicochemical properties of the ICl, chloramine-T, and electrolytic reaction products. , 1972, Biochimica et biophysica acta.

[31]  R. North.  THE ACTION OF CORTISONE ACETATE ON CELL-MEDIATED IMMUNITY TO INFECTION , 1971, The Journal of experimental medicine.

[32]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[33]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[34]  P. Marks,et al.  Differentiation of normal and neoplastic hematopoietic cells , 1978 .

[35]  P. C. Harpel.  [52] Human α2-macroglobulin , 1976 .

[36]  S. Williams,et al.  Proliferation of human peripheral blood lymphocytes induced by A23187, a streptomyces antibiotic. , 1976, Experimental cell research.

[37]  N. Kjeldgaard,et al.  Urokinase an activator of plasminogen from human urine. I. Isolation and properties. , 1957, Biochimica et biophysica acta.